Virax Biolabs Group announced that it has signed contracts to launch two new research and laboratory facilities in the United Kingdom. The Company has signed a contract to launch a laboratory facility at Scale Space. Scale Space is conveniently located in a major metropolitan hub in the heart of the unique innovation ecosystem at Imperial College London, a 23-acre research and innovation district in White City, west London. If granted approval by the regulatory agencies, the site would be instrumental in the initial launch of ViraxImmune, acting as the first laboratory for blood draw and analysis. The laboratory would also give the Company the ability to fulfill third party laboratory orders.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VRAX: